Literature DB >> 33214884

Will initial consultation patterns among undiagnosed cancer patients be the same after this COVID-19 pandemic? Experiences from the 2011 triple disaster in Fukushima, Japan.

Akihiko Ozaki1, Toyoaki Sawano2, Hiroaki Saito3, Tetsuya Tanimoto4, Masaharu Tsubokura5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33214884      PMCID: PMC7648884          DOI: 10.7189/jogh.10.020343

Source DB:  PubMed          Journal:  J Glob Health        ISSN: 2047-2978            Impact factor:   4.413


× No keyword cloud information.
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19), first broke out in Wuhan, China in December 2019, and has spread out worldwide causing a global pandemic. As cancer patients are deemed to be a high-risk population of COVID-19, the effect of COVID-19 on the cancer population and their treatment has already been widely discussed across various media and academic journals [1-3]. Briefly, it is important not only to protect cancer patients from SARS-CoV-2 infection, but also to continuously provide appropriate and timely care depending on the urgency of their conditions. However, such discussions have primarily focused on patients already diagnosed with cancerpatients waiting for treatment inception, patients already receiving treatment, and survivors in surveillance after treatment, and the short-term health effects among these populations. In contrast, little has been said regarding undiagnosed cancer patients (ie, before cancer diagnosis) and/or their long-term health consequences. When considering undiagnosed cancer patients during the COVID-19 pandemic, we believe that our experiences in Fukushima would help further develop our discussions. We have been involved in care and research on cancer patients in Fukushima following the 2011 triple disaster (earthquake, tsunami, and nuclear accident) of the Great East Japan Earthquake, witnessing how long-term health effects have developed since the onset of this complex disaster. Arguably, the radiation disaster and the pandemic would indeed be seemingly different; however, COVID-19 is caused by an intangible pathogen with relatively unknown effects, which has some similarities with radioactive substances in their influence on human behavior as both would make people isolate themselves from others. For example, in the coastal area of Fukushima, the fear of radiation exposure has persistently prevented local residents from consuming locally grown food for more than five years after the disaster, although the air radiation dose rate was demonstrated to be at an acceptable level just a few years following the disaster [4]. This means that people may change their behavioral patterns for much longer than reasonably anticipated. In the wake of the triple disaster, the most striking observation regarding cancer was an increase in the proportion of undiagnosed symptomatic breast cancer patients in the affected areas who delayed seeking initial medical consultation, and this situation has persisted for over five years after the disaster [5]. More concretely, 18.0% of the post-disaster patients delayed their initial medical consultation for 12 months or longer, while such a delay had occurred only 4.1% of the pre-disaster population (age adjusted risk ratio post- vs pre-disaster: 4.49, 95% confidence interval 1.73-11.65) [5]. Further, there is anecdotal evidence that the similar delay occurred among undiagnosed symptomatic colorectal cancer patients in the post-disaster period [6]. The most likely explanation for this is a decreased interest in seeking medical consultation for apparently non-urgent symptoms, as suggested by our in-depth interviews with some of the patients [6,7]. What should be noted is that these post-disaster changes in behavioral patterns among undiagnosed symptomatic cancer patients occurred although the local cancer care had been restored to enable the post-disaster cancer patients to receive timely initial treatment, at least six months after the disaster [8]. Similarly, when the “New Normal” is established during the COVID-19 pandemic, we are concerned that initial medical consultation among undiagnosed symptomatic cancer patients could be delayed because of the hesitance to request medical consultation promptly for fear of contracting COVID-19. Given that the current pandemic is projected to last until 2022 [9], and that this projection has been repeatedly disseminated via various media outlets, baseline motivation for medical consultation for non-urgent symptoms may decline for the next several years because of fear of infection. The same may be true with cancer screening for asymptomatic populations, given that the priority of such preventive measures may further decline in the same context. Photo: from the Jyoban Hospital of Tokiwa Founation, used with permission. Naturally since its outbreak, COVID-19 has drawn huge attention to its direct health effects and interrupted care for other conditions including cancer, as originally seen in the 2011 triple disaster in Fukushima. However, once its death toll declines and people become accustomed to the New Normal soon, an interest in the COVID-19 and its related health problems would potentially diminish all in academic, mass media and general communities, as seen following the triple disaster. In this regard, health care professionals, public health practitioners, and policy makers should have a long-term perspective to reveal and mitigate potentially diverse and long-term health effects on cancer caused by the COVID-19 pandemic. To this end, appropriate designing of researches to clarify these health issues and relevant logistics enabling such researches are both essential. In the meantime, it is important to enhance awareness of signs and symptoms suggestive of cancer among the general public and to motivate them to regularly participate in cancer screening programs and/or do appropriate self-examination and self-care. Both in research and clinical practice, cross-sectional and longitudinal collaborations involving multiple stakeholders are critical to protect health and well-beings of cancer patients in the long term. Specifically, a close attention should be paid to whether a proportion of undiagnosed symptomatic cancer patients that delay seeking health care would be increased for fear of contracting COVID-19, a lesson learned from the 2011 triple disaster that should be shared globally.
  8 in total

1.  Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study.

Authors:  Akihiko Ozaki; Shuhei Nomura; Claire Leppold; Masaharu Tsubokura; Toyoaki Sawano; Manabu Tsukada; Tomohiro Morita; Tetsuya Tanimoto; Shigehira Saji; Shigeaki Kato; Kazue Yamaoka; Yoshinori Nakata; Hiromichi Ohira
Journal:  Clin Breast Cancer       Date:  2019-09-06       Impact factor: 3.225

2.  Oncology Practice During the COVID-19 Pandemic.

Authors:  Deborah Schrag; Dawn L Hershman; Ethan Basch
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

3.  Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study.

Authors:  Akihiko Ozaki; Shuhei Nomura; Claire Leppold; Masaharu Tsubokura; Tetsuya Tanimoto; Takeru Yokota; Shigehira Saji; Toyoaki Sawano; Manabu Tsukada; Tomohiro Morita; Sae Ochi; Shigeaki Kato; Masahiro Kami; Tsuyoshi Nemoto; Yukio Kanazawa; Hiromichi Ohira
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430

4.  Social isolation and cancer management - advanced rectal cancer with patient delay following the 2011 triple disaster in Fukushima, Japan: a case report.

Authors:  Akihiko Ozaki; Claire Leppold; Toyoaki Sawano; Masaharu Tsubokura; Manabu Tsukada; Tetsuya Tanimoto; Masahiro Kami; Hiromichi Ohira
Journal:  J Med Case Rep       Date:  2017-05-16

5.  Social isolation and cancer management after the 2011 triple disaster in Fukushima, Japan: A case report of breast cancer with patient and provider delay.

Authors:  Akihiko Ozaki; Claire Leppold; Masaharu Tsubokura; Tetsuya Tanimoto; Shigehira Saji; Shigeaki Kato; Masahiro Kami; Manabu Tsukada; Hiromichi Ohira
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

6.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.

Authors:  L Zhang; F Zhu; L Xie; C Wang; J Wang; R Chen; P Jia; H Q Guan; L Peng; Y Chen; P Peng; P Zhang; Q Chu; Q Shen; Y Wang; S Y Xu; J P Zhao; M Zhou
Journal:  Ann Oncol       Date:  2020-03-26       Impact factor: 32.976

7.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.

Authors:  Stephen M Kissler; Christine Tedijanto; Yonatan H Grad; Marc Lipsitch; Edward Goldstein
Journal:  Science       Date:  2020-04-14       Impact factor: 47.728

8.  Provision of cancer care during the COVID-19 pandemic.

Authors:  James Spicer; Charlotte Chamberlain; Sophie Papa
Journal:  Nat Rev Clin Oncol       Date:  2020-06       Impact factor: 66.675

  8 in total
  2 in total

1.  Potential association of prolonged patient interval and advanced anatomic stage in breast cancer patients in the area affected by the 2011 triple disaster in Fukushima, Japan: Retrospective observational study.

Authors:  Akihiko Ozaki; Sawano Toyoaki; Manabu Tsukada; Yuki Shimada; Ayumu Kawamoto; Ji-Wei Wang; Divya Bhandari; Masaharu Tsubokura; Hiromichi Ohira
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

2.  Interruption of breast cancer care and importance of inter-hospital cooperation during the COVID-19 pandemic: A case report of advanced breast cancer in Fukushima, Japan.

Authors:  Akihiko Ozaki; Yudai Kaneda; Yuki Senoo; Masahiro Wada; Tomohiro Kurokawa; Toyoaki Sawano; Masaharu Tsubokura; Tetsuya Tanimoto; Yoshiaki Kanemoto; Tomozo Ejiri; Hiroaki Shimmura; Norio Kanzaki
Journal:  Clin Case Rep       Date:  2022-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.